Current criteria for diagnosing diabetes, based on fasting plasma glucose l
evels during administration of the oral glucose tolerance test (OGTT), are
poorly sensitive and are only modestly predictive of microvascular risk. Th
e period after administration of OGTT is far more predictive and more close
ly resembles the postprandial state where microvascular risk is elevated. H
owever, persons who do not yet exhibit symptoms of diabetes may nonetheless
have impaired glucose tolerance or dysglycemia, whereby macrovascular dise
ase can develop at a glucose level lower than the threshold for microvascul
ar disease and can progress in a graded fashion. This article reviews the f
actors that may cause dysglycemia (including insulin resistance and obesity
) and how diet, blood pressure control, and the use of statins or glycemic/
insulin sensitizing may reduce cardiovascular risk in this prediabetic popu
lation. (C) 2001 by Excerpta Medica, Inc.